Compare Star Pacific Tbk (LPLI) vs Tempo Scan Pacific Tbk. (TSPC) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Star Pacific Tbk vs Tempo Scan Pacific Tbk. — how do they compare? Star Pacific Tbk trades at Rp250 (market cap 278.56B, 813.5K 24h volume), while Tempo Scan Pacific Tbk. trades at Rp2,590 (market cap 11.36T, 1.77M 24h volume). The key difference: Tempo Scan Pacific Tbk. is far larger — about 40.8× Star Pacific Tbk's market cap, and Tempo Scan Pacific Tbk. is more actively traded (1.77M versus 813.5K). Which is the better fit depends on your goals.
| LPLI | TSPC | |
|---|---|---|
Market Cap | 278.56B | 11.36T |
Volume | 813.5K | 1.77M |
Lot | 8.14K | 17.71K |
Turnover | 204.32M | 4.61B |
Average Price | 251.17 | 2,603.9 |
Value | 204.32M | 4.61B |
Indicative Equilibrium Price | 250 | 2,590 |
Indicative Equilibrium Volume | 70 | 300 |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Star Pacific Tbk
PT Star Pacific Tbk (the Company), was established under the name of PT Asuransi Lippo Jiwa Sakti based on Deed No. 301 dated May 28, 1983 of Misahardi Wilamarta, S.H., a notary in Jakarta, which was amended by Deed No. 130 dated August 10, 1983 by the same notary, concerning the change of the Company's name to PT Asuransi Lippo Life. Furthermore, the Company's name was again changed to Lippo E-Net Tbk based on Deed No. 87 dated June 23, 2000 of Misahardi Wilamarta, S.H., a notary in Jakarta.
Read more on LPLI →About Tempo Scan Pacific Tbk.
PT. Tempo Scan Pacific Tbk (the Company) was established in the Republic of Indonesia dated 20 May 1970, under its original name PT Scanchemie within the framework of the Domestic Capital Investment Law No. 6 year 1968, as amended by Law No. 12 year 1970, based on Notarial Deed No. 37 of Ridwan Suselo, S.H. The company is famous for such pharmaceutical products as Bodrex, Hemaviton and Neo-Rheumacyl.
Read more on TSPC →
